Close Menu
Home » About Us » Our Staff » John Gilmore

John Gilmore

Staff Reporter
Phone Number
212-651-5628
Email
[email protected]

Articles Authored by John Gilmore

Jan 23, 2020

Immunis.AI Targets Late 2020 Prostate Cancer Risk Core Assay Launch

Premium

Formerly called OncoCell MDx, the Royal Oak, Michigan-based firm aims to complete a validation study for the prostate cancer risk assay within the next two months.

Jan 21, 2020

FNIH Team Selects Cancer Biomarkers in Phase I of Liquid Biopsy Reference Standards Project

Premium

Having raised $1.5 million in funding since announcing the project at a 2017 AACR meeting, the group anticipates completing the first phase of the project by Q2 2020.  

Jan 17, 2020

British Startup Biofidelity Eyes Targeted Therapy Space With Novel Reagents

Premium

The team anticipates launching its first clinical diagnostic assay, which will detect targeted, low-frequency genetic mutations in lung cancer, in 2021.

Jan 07, 2020

Circulating Tumor Cell Collection, Analysis Methods Make Headway in 2019

Premium

More groups are now using CTC capture methods alongside circulating tumor DNA tools to distinguish themselves from the crowded ctDNA detection space.

Dec 20, 2019

Interpace Biosciences Expanding Beyond Dx, Cancer With Acquisition, Name Change

Premium

The Parsippany, New Jersey-based firm expects to expand relationships with multiple biopharmaceutical companies after bolstering its biopharma services business. 

Dec 19, 2019

Stanford Researchers Apply Liquid Biopsy Tools to Molecular Fungal Detection Workflow

Premium

The team is developing a real-time PCR method to help clinicians quickly detect Aspergillus, Candida, and Mucorales infections and begin targeted antifungal therapy.

Dec 11, 2019

Colorado Center for Personalized Medicine Biobank Begins Returning Participant PGx Results

Premium

The group is mailing pharmacogenetic information back to patients, with plans to deliver genetic disease risk and carrier screening results.

Dec 10, 2019

KU-Led Team Begins Clinical Validation of Microfluidic Device for Leukemia MRD Detection

Premium

The team will present the results to the US Food and Drug Administration as part of a 510(k) application in order to commercialize the technology with Biofluidica.

Dec 05, 2019

Veracyte Pursues International Expansion With Global License Agreement

Premium

While NanoString will commercialize its nCounter for research use applications, Veracyte will move its current assays onto the platform to reach a global audience.

Nov 21, 2019

Intermountain Healthcare to Gather Utility Data as SelectHealth Covers PGx Test for Certain Employees

Premium

SelectHealth will cover PGx testing for Intermountain employees and beneficiaries with major depressive disorder who have failed treatment.

The Scan

Letting Samples Fly

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Layoffs at 23andMe

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Dusty Resistance

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

Science Studies Use Single-Cell RNA Sequencing to Study Cell States, Apply Deep Phenotyping to Pregnancy

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more. 

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.